32 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Loading...
Loading...

Gainers

  • Cidara Therapeutics, Inc. CDTX stock increased by 68.5% to $2.83 during Tuesday's pre-market session. The most recent rating by Oppenheimer, on June 06, is at Outperform, with a price target of $6.00.
  • Ardelyx, Inc. ARDX stock rose 22.4% to $4.16. The market cap stands at $255.5 million.
  • Medicines Co, Inc. MDCO stock moved upwards by 15.0% to $48.25. The market cap seems to be at $2.6 billion. The most recent rating by Citigroup, on September 03, is at Buy, with a price target of $55.00.
  • Viveve Medical, Inc. VIVE shares increased by 11.1% to $0.12. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
  • BioLine Rx, Inc. BLRX shares increased by 10.5% to $3.15.
  • Atossa Genetics, Inc. ATOS stock increased by 8.0% to $2.15. The market value of their outstanding shares is at $5.8 million.
  • Co-Diagnostics, Inc. CODX stock surged 7.5% to $1.15. The market value of their outstanding shares is at $35.7 million.
  • Guardion Health Sciences, Inc. GHSI shares increased by 3.7% to $0.26.
  • InMode, Inc. INMD stock rose 3.5% to $20.60.
  • Moderna, Inc. MRNA stock rose 3.1% to $16.22.
  • Amarin Corp, Inc. AMRN shares increased by 3.1% to $15.45. The market cap stands at $6.7 billion.
  • Sanofi, Inc. SNY stock rose 3.0% to $44.24. The most recent rating by Bernstein, on September 03, is at Outperform, with a price target of $52.00.
  • Genmab, Inc. GMAB stock rose 2.4% to $20.87. According to the most recent rating by Morgan Stanley, on August 12, the current rating is at Overweight.
  • Outlook Therapeutics, Inc. OTLK stock surged 1.9% to $1.56. The market value of their outstanding shares is at $30.3 million.
  • Heat Biologics, Inc. HTBX shares moved upwards by 1.9% to $0.52. The market cap stands at $31.8 million. The most recent rating by Brookline Capital, on July 30, is at Buy, with a price target of $8.00.
  • SELLAS Life Sciences, Inc. SLS stock surged 1.0% to $0.14. The market value of their outstanding shares is at $27.0 million.

 

Losers

  • Aridis Pharmaceuticals, Inc. ARDS shares decreased by 27.1% to $8.52 during Tuesday's pre-market session.
  • T2 Biosystems, Inc. TTOO shares plummeted 7.5% to $1.23. The market value of their outstanding shares is at $209.3 million. The most recent rating by Alliance Global Partners, on August 01, is at Neutral, with a price target of $0.40.
  • Akari Therapeutics, Inc. AKTX stock decreased by 7.2% to $1.93. The market cap stands at $28.6 million.
  • Genfit, Inc. GNFT shares decreased by 6.7% to $16.15. The market value of their outstanding shares is at $638.7 million.
  • Mallinckrodt, Inc. MNK shares decreased by 4.1% to $2.48. The most recent rating by Barclays, on August 28, is at Equal-Weight, with a price target of $5.00.
  • Cancer Genetics, Inc. CGIX shares fell 3.5% to $0.10. The market value of their outstanding shares is at $37.0 million.
  • Lannett, Inc. LCI shares decreased by 3.1% to $10.00. The market cap stands at $516.9 million. The most recent rating by SunTrust Robinson Humphrey, on August 29, is at Hold, with a price target of $10.00.
  • InflaRx, Inc. IFRX shares decreased by 2.8% to $2.76. The most recent rating by Baird, on June 06, is at Neutral, with a price target of $6.00.
  • AAC Holdings, Inc. AAC shares decreased by 2.4% to $0.59. The market cap stands at $18.9 million. According to the most recent rating by Raymond James, on August 13, the current rating is at Market Perform.
  • Grifols, Inc. GRFS shares plummeted 2.2% to $20.83. The market cap stands at $14.1 billion. The most recent rating by JP Morgan, on June 27, is at Overweight, with a price target of $22.50.
  • Tilray, Inc. TLRY shares fell 1.6% to $25.27. According to the most recent rating by Ladenburg Thalmann, on July 17, the current rating is at Neutral.
  • Fresenius Medical Care, Inc. FMS stock declined 1.5% to $33.10. The market cap stands at $21.8 billion. According to the most recent rating by BTIG, on August 01, the current rating is at Neutral.
  • OpGen, Inc. OPGN shares fell 1.4% to $7.10. The market value of their outstanding shares is at $12.3 million.
  • Cronos Group, Inc. CRON stock plummeted 1.3% to $10.88. The most recent rating by Piper Jaffray, on August 13, is at Overweight, with a price target of $18.00.
  • Dr Reddy's Laboratories, Inc. RDY stock fell 1.1% to $35.41. The market cap seems to be at $9.4 billion. The most recent rating by Barclays, on June 11, is at Equal-Weight, with a price target of $39.00.
  • Alcon, Inc. ALC shares fell 1.0% to $60.37. The market cap seems to be at $28.1 billion. The most recent rating by Credit Suisse, on August 26, is at Outperform, with a price target of $73.00.
Loading...
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...